
Skinvive by Juvederm
FDA-approved hyaluronic-acid microdroplet treatment for improved cheek skin smoothness in adults over 21.
What is SKINVIVE approved to improve?
SKINVIVE is approved as an intradermal injection to improve cheek skin smoothness in adults over age 21.
Is it the same as contouring filler?
No. It is placed as microdroplets within the cheek skin for smoothness rather than to build facial structure or substantial volume.
How long can results last?
The manufacturer reports results lasting through six months with optimal treatment; individual results vary.
What symptoms require urgent attention?
Vision change, unusual pain, white or dusky skin, weakness, facial drooping, or speech difficulty requires immediate evaluation.
What Is SKINVIVE by JUVÉDERM?
SKINVIVE is an injectable hyaluronic-acid gel placed as microdroplets within the skin. It is FDA approved to improve facial skin smoothness of the cheeks in adults over age 21.
Unlike contouring filler, SKINVIVE is intended to improve cheek skin quality rather than create substantial projection or reshape facial structure.
How It Works and What It Can Do
Hyaluronic acid helps retain moisture within the treated tissue. Small intradermal injections are distributed through the cheek area to support smoother-looking skin. The manufacturer reports improvement lasting through six months with optimal treatment, although individual duration varies.
Its approved use is cheek skin smoothness. Safety and effectiveness in other body areas have not been established in clinical studies.
Your Appointment and Recovery
Your provider reviews allergies, prior filler, medications, immune conditions, scarring or pigment history, active skin problems, pregnancy or breastfeeding, and planned laser or peel procedures.
Redness, bumps, swelling, bruising, pain, tenderness, firmness, discoloration, itching, nodules, infection, or an unsatisfactory result can occur. Many common reactions are temporary, but persistent or delayed symptoms should be evaluated.
Important Safety Information
Do not use SKINVIVE with certain severe allergies, allergy to lidocaine or relevant bacterial proteins, or prior allergic reaction to hyaluronic-acid fillers. Treatment should be postponed over active sores, pimples, rashes, cysts, or infection.
Rare intravascular injection can cause skin injury, vision abnormalities, blindness, or stroke. Seek immediate care for vision change, unusual pain, white or dusky skin, weakness, facial drooping, or speech difficulty.
SKINVIVE in Coral Gables
Schedule an assessment at SkinHealth, 6931 S Red Road.
Results vary. Review full product information with your provider.